Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia

1 Dec 2020

Abstract excerpt

BACKGROUND & OBJECTIVES: Gestational trophoblastic neoplasia (GTN) is a chemosensitive malignancy with an excellent cure rate. The primary objective of the present study was to determine the predictors of chemoresistance and disease relapse, and the secondary objective was to appraise the WHO/FIGO risk scoring and course of disease in women with GTN. METHODS: In this retrospective study, case records of women...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gestational Trophoblastic Disease Studies
Share to Maternal and fetal healthcare
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34145099
DOI: 10.4103/ijmr.ijmr_2585_19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasiaPMID 34145099Read ↗

Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed diseaseSemantic proximity Read ↗

PREDICT‐ GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?Semantic proximity Read ↗

Gestational Trophoblastic Disease in BrazilSemantic proximity Read ↗

Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Semantic proximity Read ↗

Understanding and management of gestational trophoblastic diseaseSemantic proximity Read ↗

Advances in the diagnosis and early management of gestational trophoblastic diseaseSemantic proximity Read ↗

Identification of microRNA signature in the progression of gestational trophoblastic diseaseSemantic proximity Read ↗

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasiaSemantic proximity Read ↗

A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expressionSemantic proximity Read ↗

Clinicopathological Predictors of Recurrence in Uterine Sarcomas – A Narrative ReviewSemantic proximity Read ↗

Epidemiology and aetiology of gestational trophoblastic diseasesSemantic proximity Read ↗

The role of trophoblastic epigenetic reprogrammation in benign tumor cells on malignant progression: A molecular hypothesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.